Listed

Oramed Pharmaceuticals Inc.

ORMPNasdaqCIK 1176309HealthcareFiscal year ends Dec 31

Reports and events: 334 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Oramed Pharmaceuticals Inc., Reports and events
FiledFormWhat it isAccession number
2024-06-1017:28 ET8-K5.02 Departure or appointment of officers or directors0001213900-24-051355
2024-05-1318:00 ET8-K5.02 Departure or appointment of officers or directors0001213900-24-041847
2024-05-0917:00 ET10-QQuarterly reportPeriod 2024-03-310001213900-24-041364
2024-05-0609:00 ET8-K8.01 Other events0001213900-24-039909
2024-03-2221:30 ETSC 13DOwnership report, active investor0001213900-24-025263
2024-03-1908:00 ET8-K8.01 Other events0001213900-24-023721
2024-03-1817:15 ET8-K5.02 Departure or appointment of officers or directors0001213900-24-023584
2024-03-1817:05 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001213900-24-023571
2024-03-0617:00 ET10-KAnnual reportPeriod 2023-12-310001213900-24-020485
2024-02-2008:42 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-24-015108
2024-01-2316:45 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001213900-24-005780
2024-01-1916:45 ET8-K5.02 Departure or appointment of officers or directors0001213900-24-004905
2023-12-2109:26 ET8-K8.01 Other events0001213900-23-097505
2023-12-1816:45 ET8-K5.02 Departure or appointment of officers or directors0001213900-23-096536
2023-11-0917:10 ET10-QQuarterly reportPeriod 2023-09-300001213900-23-085310
2023-09-2616:34 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-23-079586
2023-09-1308:47 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-23-076238
2023-08-2218:06 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-23-069538
2023-08-1017:00 ET10-QQuarterly reportPeriod 2023-06-300001213900-23-065678
2023-08-0908:30 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001213900-23-064786
2023-08-0709:20 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-23-063876
2023-07-1317:00 ET8-K5.07 Shareholder vote results0001213900-23-056806
2023-05-3117:20 ETDEF 14AProxy statementPeriod 2023-07-130001213900-23-044530
2023-05-1117:01 ET10-QQuarterly reportPeriod 2023-03-310001213900-23-038593
2023-05-0116:51 ET8-K5.02 Departure or appointment of officers or directors0001213900-23-034728
2023-03-0617:01 ET10-KAnnual reportPeriod 2022-12-310001213900-23-017837
2023-02-2717:05 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001213900-23-014884
2023-01-1220:00 ET8-K8.01 Other events0001213900-23-002343
2022-12-1207:39 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-22-078902
2022-11-1407:55 ET8-K8.01 Other events0001213900-22-071607
2022-11-1016:32 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-22-071230
2022-11-1016:30 ET10-QQuarterly reportPeriod 2022-09-300001213900-22-071222
2022-09-1917:05 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001213900-22-057036
2022-09-1308:52 ET8-K8.01 Other events0001213900-22-055429
2022-09-0817:06 ET8-K8.01 Other events0001213900-22-054868
2022-08-1016:45 ET10-QQuarterly reportPeriod 2022-06-300001213900-22-046399
2022-07-0708:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-22-037750
2022-06-3016:15 ET8-K5.07 Shareholder vote results0001213900-22-036294
2022-06-0216:30 ETDEF 14AProxy statementPeriod 2022-06-300001213900-22-030956
2022-05-1217:04 ET10-QQuarterly reportPeriod 2022-03-310001213900-22-026004
2022-04-0408:25 ET8-K5.02 Departure or appointment of officers or directors0001213900-22-017667
2022-02-2817:00 ET8-K5.03 Amendment to articles or bylaws0001213900-22-009794
2022-01-1209:41 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-22-001660
2022-01-1116:45 ET10-QQuarterly reportPeriod 2021-11-300001213900-22-001563
2021-12-0808:00 ET8-K8.01 Other events0001213900-21-064085
2021-12-0717:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-21-063984
2021-11-2417:15 ET10-KAnnual reportPeriod 2021-08-310001213900-21-062009
2021-11-0417:17 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001213900-21-056803
2021-10-2908:33 ET8-K8.01 Other events0001213900-21-055258
2021-09-0216:49 ETSC 13D/AOwnership report, active investor, amended0001213900-21-046415

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 04:14 ET. Listed shows no prices and gives no investment advice.